Angioplasty Balloons Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and End User

Description

According to our latest study on " Angioplasty Balloons Market Forecast to 2030 - Global Analysis -Type, Application, End User, and Geography," the market was valued at US$ 2.71 billion in 2022 and is expected to reach US$ 3.60 billion by 2030; it is estimated to register a CAGR of 3.6% from 2022 to 2030.

An angioplasty is a technique used to widen narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, reduced revascularization rates, and lower costs compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries.

The initiative HEARTS in the Americas is led by the Ministries of Health with the participation of local stakeholders and the technical cooperation of the Pan American Health Organization (PAHO). The Initiative is being executed in more than 1,400 health centers in 22 nations across the region. By 2025, HEARTS will be the model for cardiovascular risk management, which includes diseases such as hypertension, diabetes, and dyslipidemia, in primary health care in the Americas.

Moreover, in Europe, public spending on healthcare has grown faster than domestic spending, but mainly in high-income countries. The European Commission's EU4Health program, the Next Generation Recovery Funds, and the Horizon Europe Research Funds offer an opportunity to address the burden of cardiovascular diseases and improve the cardiovascular health of citizens by implementing preventative measures identified in an EU Action Plan for better cardiovascular health. This plan covers the overall patient journey, from prevention and early detection to access to care and treatment to quality of life and functioning status, considering the vital role of digitization and innovation at all stages. Thus, increasing healthcare spending and government-led initiatives regarding heart health to create growth opportunity in angioplasty balloons market.

By Type, Angioplasty Balloons Market-Based Insights

Based on type, the angioplasty balloons market is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest angioplasty balloons market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022-2030. In endovascular therapy, drug-coated balloons (DCB), primarily paclitaxel-coated balloons, are being utilized more frequently to improve the low patency results of angioplasty. When addressing hemodialysis access dysfunction, the use of drug-eluting balloons might, in the short run, require less reintervention and associated healthcare costs than simple balloon angioplasty.

By End User, Angioplasty Balloons Market-Based Insights

The angioplasty balloons market, by end user, hospitals, ambulatory surgery centers, and others. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022-2030, owing to the minimum hospital stay requirements and the availability of advanced services. In addition, treatments performed in ambulatory surgery centers are cost-effective, which helps cut down on total medical costs. All these factors contribute to the growth of the ambulatory surgery center segment.

European Society of World Heart Federation, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the angioplasty balloons market.

Product Code: TIPHE100001278

1. Introduction

1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness Analysis

3. Research Methodology

4. Angioplasty Balloon Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain

5. Angioplasty Balloon Market - Key Market Dynamics

5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints

6. Angioplasty Balloon Market - Global Market Analysis

6.1 Angioplasty Balloon - Global Market Overview
6.2 Angioplasty Balloon - Global Market and Forecast to 2030

7. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By Type, 2020-2030

7.1 Overview
7.2 Normal Balloons
7.3 Drug Eluting Balloons
7.4 Scoring Balloons
7.5 Cutting Balloon

8. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By Application, 2020-2030

8.1 Overview
8.2 Coronary
8.3 Peripheral

9. Angioplasty Balloon Market - Revenue Analysis (USD Million) - By End User, 2020-2030

9.1 Overview
9.2 Hospitals
9.3 Ambulatory Surgery Centers
9.4 Cath Labs

10. Angioplasty Balloon Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

10.1 North America
- 10.1.1 North America Angioplasty Balloon Market Overview
- 10.1.2 North America Angioplasty Balloon Market Revenue and Forecasts to 2030
- 10.1.3 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Type
- 10.1.4 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Material
- 10.1.5 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Application
- 10.1.6 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By End User
- 10.1.7 North America Angioplasty Balloon Market Revenue and Forecasts and Analysis - By Countries
  - 10.1.7.1 United States Angioplasty Balloon Market
    - 10.1.7.1.1 United States Angioplasty Balloon Market, by Type
    - 10.1.7.1.2 United States Angioplasty Balloon Market, by Material
    - 10.1.7.1.3 United States Angioplasty Balloon Market, by Application
    - 10.1.7.1.4 United States Angioplasty Balloon Market, by End User
  - 10.1.7.2 Canada Angioplasty Balloon Market
    - 10.1.7.2.1 Canada Angioplasty Balloon Market, by Type
    - 10.1.7.2.2 Canada Angioplasty Balloon Market, by Material
    - 10.1.7.2.3 Canada Angioplasty Balloon Market, by Application
    - 10.1.7.2.4 Canada Angioplasty Balloon Market, by End User
  - 10.1.7.3 Mexico Angioplasty Balloon Market
    - 10.1.7.3.1 Mexico Angioplasty Balloon Market, by Type
    - 10.1.7.3.2 Mexico Angioplasty Balloon Market, by Material
    - 10.1.7.3.3 Mexico Angioplasty Balloon Market, by Application
    - 10.1.7.3.4 Mexico Angioplasty Balloon Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

10.2 Europe
- 10.2.1 Germany
- 10.2.2 France
- 10.2.3 Italy
- 10.2.4 Spain
- 10.2.5 United Kingdom
- 10.2.6 Rest of Europe
10.3 Asia-Pacific
- 10.3.1 Australia
- 10.3.2 China
- 10.3.3 India
- 10.3.4 Japan
- 10.3.5 South Korea
- 10.3.6 Rest of Asia-Pacific
10.4 Middle East and Africa
- 10.4.1 South Africa
- 10.4.2 Saudi Arabia
- 10.4.3 U.A.E
- 10.4.4 Rest of Middle East and Africa
10.5 South and Central America
- 10.5.1 Brazil
- 10.5.2 Argentina
- 10.5.3 Rest of South and Central America

11. Industry Landscape

11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration

13. Angioplasty Balloon Market - Key Company Profiles

13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

13.2 Boston Scientific Corporation
13.3 Cardinal Health
13.4 Cook Medical
13.5 BD (C. R. Bard, Inc.)
13.6 ENDOCOR GmbH
13.7 Medtronic
13.8 Spectranetics
13.9 BIOTRONIK
13.10 Terumo Medical Corporation

14. Appendix

14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud